The World of Health & Medicine News

Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals

Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals

 CGMs may inaccurately estimate blood sugar levels in healthy individuals, leading to unnecessary dietary changes.

  • Discrepancies arise because CGMs measure glucose in interstitial fluid, not directly in blood, causing potential errors

As continuous glucose monitors (CGMs) become more widely used to help manage blood sugar levels in individuals with diabetes, findings from the University of Bath suggest that these devices may not be as accurate as commonly believed. The study authors, who published their results in The American Journal of Clinical Nutrition, noted that CGMs could be overestimating blood sugar levels in healthy adults that are using these devices to track how different foods affect their glucose levels, leading to unnecessary diet changes.

CGMs are fantastic tools for people with diabetes because even if a measurement isn’t perfectly accurate, it’s still better than not having a measurement at all. However, for someone with good glucose control, they can be misleading based on their current performance. For healthy individuals, relying on CGMs could lead to unnecessary food restrictions or poor dietary choices,” Javier Gonzalez, PhD, professor at the University of Bath, said in a news release

spot_img

Explore more

spot_img

Foods Richer in Vitamin A Than Carrots: Six Lesser-Known Nutrient Powerhouses

Foods Richer in Vitamin A Than Carrots: Six Lesser-Known Nutrient Powerhouses Vitamin A is an essential nutrient for maintaining overall health, playing a vital role...

Bavarian Nordic signs EU smallpox and mpox vaccine contract for up...

Bavarian Nordic signs EU smallpox and mpox vaccine contract for up to 8 million doses Bavarian Nordic announced on Friday a new contract with the...

WHO says mpox now detected in more countries, with 17 deaths...

WHO says mpox now detected in more countries, with 17 deaths in Africa over six weeks The World Health Organization (WHO) said on Friday that...

Metsera the US obesity biotech at centre of Novo, Pfizer bidding...

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war Metsera has become the obesity drug market's hottest ticket. The New York-based biotech is...

Eli Lilly says weight-loss pill a candidate for speedy approval under...

Eli Lilly says weight-loss pill a candidate for speedy approval under new US programme Eli Lilly said its experimental weight-loss pill met most criteria for...

BridgeBio surges as muscle disorder drug scores ‘best case’ trial win

BridgeBio surges as muscle disorder drug scores 'best case' trial win BridgeBio Pharma (BBIO.O), opens new tab said on Monday its experimental drug for a rare muscle...

US FDA warns four firms over unapproved fluoride drugs for children

US FDA warns four firms over unapproved fluoride drugs for children The U.S. Food and Drug Administration said on Friday it warned four companies that...

Inhibrx shares surge after bone cancer drug slows disease progression in...

Inhibrx shares surge after bone cancer drug slows disease progression in trial Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of...